ECONOMIC AND OPERATIONAL IMPACT OF BLOOD CONTROL PERIPHERAL INTRAVENOUS CATHETERS IN A HOSPITAL SETTING IN INDONESIA...
Author(s)
Yulia Djatiwardani, MD1, Pinaki Ghosh, PhD2.
1B. Braun Medical Indonesia, Jakarta, Indonesia, 2B. Braun Medical Industries, Penang, Malaysia, Malaysia.
1B. Braun Medical Indonesia, Jakarta, Indonesia, 2B. Braun Medical Industries, Penang, Malaysia, Malaysia.
OBJECTIVES: Peripheral intravenous catheterization (PIVC) is a common hospital procedure associated with blood leakage events that may increase costs, nursing workload, and contamination risks. This study aimed to estimate the economic and operational impact of safety PIVCs with integrated blood control technology compared to PIVCs without blood control in a hospital setting.
METHODS: A static decision tree model was conceptualized to estimate annual cost-benefit and budget impact of implementing safety PIVC with blood control vs. use of safety PIVC without blood control) from a hospital perspective considering a 300-bed hospital with 80% occupancy and average length of stay of 3 days for each patient. Clinical and operational inputs were obtained from published literature and local data sources. Outcomes included total cost of care, blood leakage events, and nursing time. Costs included device acquisition and blood leakage management (linen replacement, gloves, and cleaning supplies). Time associated with cannulation and cleaning procedures was also incorporated.
RESULTS: The model results showed that use of safety PIVC with blood control resulted in annual blood leakage events’ reduction from 39,478 to 1,431, avoiding approximately 38,048 events. Despite higher device acquisition costs, total annual cost of care was reduced from IDR 1,492,003,200 to IDR 908,908,400, generating cost savings of IDR 583,094,800 (39.08%). The results showed that incremental costs of safety PIVC with blood control over safety PIVC without blood control is offset by higher total costs of blood leakage event management for safety PIVC without blood control. Nursing time was reduced from 4,179 hours to 1,276 hours, corresponding to a 69.48% reduction and saving approximately 2,904 hours annually.
CONCLUSIONS: Implementation of PIVCs with blood control technology substantially reduces blood leakage events, nursing workload, and total cost of care. These findings suggest that blood control PIVCs represent a cost-saving strategy with operational benefits in hospital settings.
METHODS: A static decision tree model was conceptualized to estimate annual cost-benefit and budget impact of implementing safety PIVC with blood control vs. use of safety PIVC without blood control) from a hospital perspective considering a 300-bed hospital with 80% occupancy and average length of stay of 3 days for each patient. Clinical and operational inputs were obtained from published literature and local data sources. Outcomes included total cost of care, blood leakage events, and nursing time. Costs included device acquisition and blood leakage management (linen replacement, gloves, and cleaning supplies). Time associated with cannulation and cleaning procedures was also incorporated.
RESULTS: The model results showed that use of safety PIVC with blood control resulted in annual blood leakage events’ reduction from 39,478 to 1,431, avoiding approximately 38,048 events. Despite higher device acquisition costs, total annual cost of care was reduced from IDR 1,492,003,200 to IDR 908,908,400, generating cost savings of IDR 583,094,800 (39.08%). The results showed that incremental costs of safety PIVC with blood control over safety PIVC without blood control is offset by higher total costs of blood leakage event management for safety PIVC without blood control. Nursing time was reduced from 4,179 hours to 1,276 hours, corresponding to a 69.48% reduction and saving approximately 2,904 hours annually.
CONCLUSIONS: Implementation of PIVCs with blood control technology substantially reduces blood leakage events, nursing workload, and total cost of care. These findings suggest that blood control PIVCs represent a cost-saving strategy with operational benefits in hospital settings.
Conference/Value in Health Info
2026-09, ISPOR Asia Pacific 2026, Bangkok, Thailand
Value in Health, Volume 55, Issue S1
Code
EE10
Topic
Economic Evaluation
Topic Subcategory
Budget Impact Analysis
Disease
No Additional Disease & Conditions/Specialized Treatment Areas, SDC: Infectious Disease (non-vaccine)